The composite diagnostic or laboratory reagent market in Spain has shown a marked upward trend from 2013 to 2023, with significant annual growth rates culminating in a sold production value of 1,492.2 million euros by 2023. Notably, there was a pronounced acceleration in growth from 2019 to 2021, with year-on-year variations peaking at 69.28% in 2021. The surge in value continued, albeit at a decelerating rate, with a notable 28.51% increase in 2023. The compound annual growth rate (CAGR) over the last five years was a robust 39.83%, reflecting strong market expansion.
The forecast indicates continued growth from 2024 to 2028, projecting that the market will reach 3,098.2 million euros by 2028. The forecasted five-year CAGR is 11.23%, indicating a steady but more tempered growth compared to recent years, with an overall forecasted growth rate of 70.24% over the next five years.
Future trends to watch for include advancements in diagnostic technologies, increasing demand for personalized medicine, and potential regulatory changes. Market dynamics could also be influenced by the development of new diseases or significant public health shifts, thus affecting the demand for diagnostic reagents.
